Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 37, 2007 - Issue 7
282
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Disposition of desloratadine in healthy volunteers

, , , , , , , , & show all
Pages 770-787 | Received 02 Apr 2007, Accepted 21 May 2007, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shotaro Uehara, Nao Yoneda, Yuichiro Higuchi, Hiroshi Yamazaki & Hiroshi Suemizu. (2020) Metabolism of desloratadine by chimeric TK-NOG mice transplanted with human hepatocytes. Xenobiotica 50:6, pages 733-740.
Read now
Jean-Marie Nicolas, Pascal Espie & Mathieu Molimard. (2009) Gender and interindividual variability in pharmacokinetics. Drug Metabolism Reviews 41:3, pages 408-421.
Read now
Shu-Feng Zhou, Jun-Ping Liu & Balram Chowbay. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:2, pages 89-295.
Read now

Articles from other publishers (23)

Shotaro Uehara, Hiroshi Suemizu & Hiroshi Yamazaki. 2022. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary 307 328 .
Suguru Kato, Abhi Shah, Mihaela Plesescu, Yoshinari Miyata, Jayaprakasam Bolleddula, Swapan Chowdhury & Xiaochun Zhu. (2020) Prediction of Human Disproportionate and Biliary Excreted Metabolites Using Chimeric Mice with Humanized Liver. Drug Metabolism and Disposition 48:10, pages 934-943.
Crossref
Zhongyang Shi, Chenguang Wang & Changquan Calvin Sun. (2020) Molecular Origin of the Distinct Tabletability of Loratadine and Desloratadine: Role of the Bonding Area – Bonding Strength Interplay. Pharmaceutical Research 37:7.
Crossref
Katja Berginc, Nadica Sibinovska, Simon Žakelj, Jurij Trontelj & Igor Legen. (2020) Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way. Acta Pharmaceutica 70:2, pages 131-144.
Crossref
Matti K. Itkonen, Aleksi Tornio, Mikko Neuvonen, Pertti J. Neuvonen, Mikko Niemi & Janne T. Backman. (2019) Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In Humans. Drug Metabolism and Disposition 47:4, pages 377-385.
Crossref
R.E. White. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 1 33 .
Jörg Täubel, Georg Ferber, Sara Fernandes, Ulrike Lorch, Eva Santamaría & Iñaki Izquierdo. (2016) Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial. PLOS ONE 11:9, pages e0163020.
Crossref
Shufeng Zhou. 2016. Cytochrome P450 2D6. Cytochrome P450 2D6 139 288 .
Ting Wang, Kun Zhang, Tingting Li, Lin He, Huiru Xie, Xuehua Jiang & Ling Wang. (2015) Prevalence of Desloratadine Slow-metabolizer Phenotype and Food-dependent Pharmacokinetics of Desloratadine in Healthy Chinese Volunteers. Clinical Drug Investigation 35:12, pages 807-813.
Crossref
Faraz Kazmi, Phyllis Yerino, Joanna E. Barbara & Andrew Parkinson. (2015) Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor. Drug Metabolism and Disposition 43:9, pages 1294-1302.
Crossref
X Han, SK Quinney, Z Wang, P Zhang, J Duke, Z Desta, JS Elmendorf, DA Flockhart & L Li. (2015) Identification and Mechanistic Investigation of Drug–Drug Interactions Associated With Myopathy: A Translational Approach. Clinical Pharmacology & Therapeutics 98:3, pages 321-327.
Crossref
Faraz Kazmi, Joanna E. Barbara, Phyllis Yerino & Andrew Parkinson. (2015) A Long-Standing Mystery Solved: The Formation of 3-Hydroxydesloratadine Is Catalyzed by CYP2C8 But Prior Glucuronidation of Desloratadine by UDP-Glucuronosyltransferase 2B10 Is an Obligatory Requirement. Drug Metabolism and Disposition 43:4, pages 523-533.
Crossref
Lyndsee Baumann-Birkbeck, Gary D. Grant, Shailendra Anoopkumar-Dukie & Justin J. Kavanagh. (2014) Drowsiness and motor responses to consecutive daily doses of promethazine and loratadine. Clinical Neurophysiology 125:12, pages 2390-2396.
Crossref
Natasha Penner. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics 1 3 .
R. Scott Obach. (2013) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery and Pharmacotherapy. Pharmacological Reviews 65:2, pages 578-640.
Crossref
Alexander V. LyubimovSilvi A. Chacko, Ragu Ramanathan, W. Griffith Humphreys & Jonathan L. Josephs. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 38 .
Nancy Hakooz & Isam I. Salem. (2012) Prevalence of desloratadine poor metabolizer phenotype in healthy Jordanian males. Biopharmaceutics & Drug Disposition 33:1, pages 15-21.
Crossref
Lan Gao, Jing Li, Claudia Kasserra, Qi Song, Ali Arjomand, David Hesk & Swapan K Chowdhury. (2011) Precision and Accuracy in the Quantitative Analysis of Biological Samples by Accelerator Mass Spectrometry: Application in Microdose Absolute Bioavailability Studies. Analytical Chemistry 83:14, pages 5607-5616.
Crossref
Shu-Feng Zhou. (2009) Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance. Clinical Pharmacokinetics 48:12, pages 761-804.
Crossref
Ragu Ramanathan, S Çömezoglu & W Humphreys. 2009. Using Mass Spectrometry for Drug Metabolism Studies, Second Edition. Using Mass Spectrometry for Drug Metabolism Studies, Second Edition 127 203 .
Guodong Chen, Ibrahim Daaro, Birendra N. Pramanik & John J. Piwinski. (2009) Structural characterization of in vitro rat liver microsomal metabolites of antihistamine desloratadine using LTQ-Orbitrap hybrid mass spectrometer in combination with online hydrogen/deuterium exchange HR-LC/MS . Journal of Mass Spectrometry 44:2, pages 203-213.
Crossref
Petia A. Shipkova, Jonathan L. Josephs & Mark Sanders. 2008. Mass Spectrometry in Drug Metabolism and Pharmacokinetics. Mass Spectrometry in Drug Metabolism and Pharmacokinetics 191 221 .
Dil M. Ramanathan & Richard M. Lelacheur. 2008. Mass Spectrometry in Drug Metabolism and Pharmacokinetics. Mass Spectrometry in Drug Metabolism and Pharmacokinetics 1 85 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.